Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,816.89
(
-0.11%
)
US TECH 100
24,499.60
(
0.38%
)
Dow Jones
47,916.57
(
-0.56%
)
Brent Oil
92.41
(
0.00%
)
Bitcoin
73,148.28
(
0.23%
)
News Focus
News Focus
Post# of 257384
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122860
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 145521

Monday, 05/18/2015 9:46:49 AM

Monday, May 18, 2015 9:46:49 AM

Post# of 257384
ENDP buys Par Pharma, a generic-drug company that went private in 2012, for $8.1B in cash and stock:

http://finance.yahoo.com/news/endo-acquire-par-pharmaceutical-strategically-103000230.html

TPG, a leading private-equity firm, paid $1.9B for Par in Jul 2012 (#msg-77533202), and thereby quadrupled their investment in less than three years! Such returns are possible thanks to a bull market the availability of cheap debt.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today